Search the collection

3 results for Mitsudomi,+Tetsuya,+Prof

Sort by:

Sort by

Limit results to:

20 per page

3 results for Mitsudomi,+Tetsuya,+Prof

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial
Author / Creator:Hida, Toyoaki, MD ; Nokihara, Hiroshi, MD ; Kondo, Masashi, MD ; Kim, Young Hak, MD ; Azuma, Koichi, MD ; Seto, Takashi, MD ; Takiguchi, Yuichi, Prof ; Nishio, Makoto, MD ; Yoshioka, Hiroshige, MD ; Imamura, Fumio, MD ; Hotta, Katsuyuki, Prof ; Watanabe, Satoshi, MD ; Goto, Koichi, MD ; Satouchi, Miyako, MD ; Kozuki, Toshiyuki, MD ; Shukuya, Takehito, MD ; Nakagawa, Kazuhiko, Prof ; Mitsudomi, Tetsuya, Prof ; Yamamoto, Nobuyuki, Prof ; Asakawa, Takashi, PhD ; Asabe, Ryoichi, MS ; Tanaka, Tomohiro, MS ; Tamura, Tomohide, Dr
Publisher:England: Elsevier Ltd
Journal title:The Lancet (British edition), 2017-07, Vol.390 (10089), p.29-39
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study
Author / Creator:Goss, Glenwood, Dr Prof ; Tsai, Chun-Ming, Prof ; Shepherd, Frances A, Prof ; Bazhenova, Lyudmila, Prof ; Lee, Jong Seok, MD ; Chang, Gee-Chen, MD ; Crino, Lucio, MD ; Satouchi, Miyako, MD ; Chu, Quincy, MD ; Hida, Toyoaki, MD ; Han, Ji-Youn, Prof ; Juan, Oscar, MD ; Dunphy, Frank, Prof ; Nishio, Makoto, MD ; Kang, Jin-Hyoung, MD ; Majem, Margarita, MD ; Mann, Helen, MSc ; Cantarini, Mireille, MD ; Ghiorghiu, Serban, MD ; Mitsudomi, Tetsuya, Prof
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2016-12, Vol.17 (12), p.1643-1652
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
ArticlesPeer ReviewedFull Text
Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, pha...
Author / Creator:Vansteenkiste, Johan F, Prof Dr ; Cho, Byoung Chul, MD ; Vanakesa, Tonu, MD ; De Pas, Tommaso, MD ; Zielinski, Marcin, Prof ; Kim, Moon Soo, MD ; Jassem, Jacek, Prof ; Yoshimura, Masahiro, MD ; Dahabreh, Jubrail, MD ; Nakayama, Haruhiku, MD ; Havel, Libor, MD ; Kondo, Haruhiko, MD ; Mitsudomi, Tetsuya, Prof ; Zarogoulidis, Konstantinos, Prof ; Gladkov, Oleg A, MD ; Udud, Katalin, MD ; Tada, Hirohito, MD ; Hoffman, Hans, Prof ; Bugge, Anders, MD ; Taylor, Paul, MD ; Gonzalez, Emilio Esteban, Prof ; Liao, Mei Lin, Prof ; He, Jianxing, MD ; Pujol, Jean-Louis, Prof ; Louahed, Jamila, PhD ; Debois, Muriel, MSc ; Brichard, Vincent, MD ; Debruyne, Channa, MD ; Therasse, Patrick, MD ; Altorki, Nasser, MD
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2016-06, Vol.17 (6), p.822-835
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Export record to excel

Export this record

Export record to excel

Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial

Export this record

Export record to excel

Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study

Export this record

Export record to excel

Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, pha...

Refine your search